The lawsuit also argues that Zepbound has been proven to be more effective for weight loss, and, on its formulary page for the switch, CVS acknowledges that studies with that implication exist while saying "real-world evidence suggests the two are comparable." "Because of their different methods of action, different clinical outcomes, and different side effects for individual patients, Zepbound and Wegovy are not clinically interchangeable," the plaintiffs said in their complaint
Rated 4 out of 5 Willa Pelkey Verified review - view original Did I just order 1 mo
it is about metabolic health
Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis
Wegovy is part of the same class of drugs as Ozempic and Mounjaro, known as GLP-1 RAs, which mimic the hormone that stimulates the digestive system, essentially telling the body it is full after eating